A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

The US is in the throes an unusually intense and severe flu season, with hospitalization rates topping the levels seen with ...

Carlson began her career as an associate at Dentons in 2007 and was promoted to partner in 2017. She holds a bachelor of arts ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...

Here's what you need to know about the Foy-ODK Sportsmanship Trophy before Saturday's Alabama men's basketball game vs Auburn ...

The chaos and uncertainty surrounding vital AIDS relief programs have needlessly threatened millions of lives, writes Drs.

Two MSU sororities hosted their 18th annual Biennial Beautillion where they awarded two students with scholarships.

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

When infection rates rise—or in extreme cases—a pandemic hits, it's impossible to test everyone. Time, money and resources ...

Compared with placebo, fostamatinib did not increase the number of oxygen-free days among adults hospitalized with COVID-19 and hypoxemia.